Upcoming Q3FY26 Earnings Call Scheduled for January 30, 2026
Strides Pharma Science Ltd · STAR · BSE ·
• Strides Pharma has scheduled an earnings call to discuss Q3FY26 and nine months ended December 31, 2025 financial results • The call will feature Badree Komandur (Managing Director & Group CEO) and Vikesh Kumar (Group CFO) • Investors can join via pre-registration link or throu…